Wealth Enhancement Trust Services’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Wealth Enhancement Trust Services's INMB Position: Q3 2026 in Review
Wealth Enhancement Trust Services sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 42 shares — an estimated $68 sold.
Wealth Enhancement Trust Services first reported a position in INMB in Q2 2026 and held it in 1 quarter. The position peaked at $68 in Q2 2026. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Wealth Enhancement Trust Services reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Trust Services sold 42 INmune Bio shares in Q3 2026, an estimated $68.
- Wealth Enhancement Trust Services first reported a position in INmune Bio in Q2 2026 and held it in 1 quarter.
- Wealth Enhancement Trust Services's INmune Bio position peaked at $68 in Q2 2026.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.